Insights / Experience Fenwick Represents Achieve Life Sciences in $45 Million Public Offering July 10, 2025
Insights / Publication William Skinner Explains Big Beautiful Bill’s QSBS Upshot in Tax Notes July 9, 2025
Insights / Experience Fenwick Represents Formation Bio in its Licensing Agreement with Sanofi July 8, 2025
Insights / Publication Fenwick’s Kat Duncan and Al Cooper Share Q1 2025 VC Trends with Venture Capital Journal July 8, 2025
Insights / Media Coverage New Fenwick Office is ‘Just the Start’ in Boston, Heidi Erlacher Tells Managing IP July 3, 2025